Analysts' Actions: A BBY FDX JCP UPS

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Agilent ( A) was initiated with an outperform rating at Leerink Swann. Company can continue to deliver organic growth over the next several years, Leerink Swann said.

Best Buy ( BBY) was upgraded at Jefferies to buy. $24 price target. Company appears to be at a positive inflection point, Jefferies said.

Bright Horizons ( BFAM) was initiated with a neutral rating at J.P. Morgan. While well-positioned to capture growth opportunities, valuation is fairly reflected in the stock, J.P. Morgan said. Price target is $30.

Bright Horizons was initiated with an outperform rating at Credit Suisse. $35 price target. Company can continue to gain market share over the coming quarters, Credit Suisse said.

Dean Foods ( DF) was upgraded at Credit Suisse. $21 price target. Market is undervaluing the company ahead of the WWAV distribution, Credit Suisse said.

Discover ( DFS) was upgraded at William Blair to outperform. Company's management team is underappreciated by investors, William Blair said.

FedEx ( FDX) was initiated with an outperform rating at Credit Suisse. $124 price target. Company can generate consistent annual sales growth and expand margins, Credit Suisse said.

Greenhill & Co. ( GHL) was upgraded to buy at TheStreet Ratings.

Harris ( HRS) was downgraded at Oppenheimer to underperform from perform. Company will likely struggle to meet its second-half guidance, Oppenheimer said.

Home Properties ( HME) was upgraded to buy at TheStreet Ratings.

J.C. Penney ( JCP) was downgraded at Citigroup to neutral. The concern is that JCP's return to topline growth will take longer than expected, Citi said. The 2013 EPS estimate was lowered and the new price target is $15.

JC Penney was downgraded at Oppenheimer to perform from outperform. Near-term risks could derail a potential recovery, Oppenheimer said.

United Parcel Service ( UPS) was initiated with an outperform rating at Oppenheimer. $95 price target. Company is leveraged to a gradual domestic economic recovery, Oppenheimer said.

Zions Bancorporation ( ZION) was initiated with an outperform rating at BMO Capital. $30 price target. Company has solid core earnings power, BMO Capital said.

STOCK COMMENTS/EPS CHANGES

Copano Energy ( CPNO) price target and estimates were raised at UBS. Estimates were increased through 2014 after Copano reported fourth-quarter earnings. The price target increased to $40 to account for the pending acquisition by Kinder Morgan ( KMI).

Cree ( CREE) price target and estimates were raised at Sterne Agee. Estimates were increased through 2014. The exclusive deal with Home Depot ( HD) to sell its LED light bulbs and gross margin tailwinds will benefit the company, Sterne Agee said. Price target is now $64.

Cree price target and estimates were raised at UBS. Estimates were increased through 2014. The deal with Home Depot and LED bulb pricing will drive growth, UBS said. Price target is now $51.

Darden ( DRI) estimates, price target were reduced at Credit Suisse. Estimates were cut through 2015. Olive Garden continues to face challenges, Credit Suisse said. Neutral rating and new $45 price target.

Gilead Sciences ( GILD) price target was raised at Lazard Capital Markets to $58. Visit with specialist highlights significant HCV opportunity, Lazard Capital Markets said.

News Corp. ( NWSA) price target was raised at Lazard Capital Markets to $35. Fox Sports 1 could be a 5% EPS lift, Lazard Capital Markets said. Buy rating.

VeriFone ( PAY) price target and estimates were cut at UBS. Estimates were cut through 2014 based on management's updated guidance. The company needs to recapture share and revitalize its underperforming products/markets, UBS said. Price target was reduced to $25.

Pinnacle West Capital ( PNW) price target and estimates were raised at UBS. 2013 earnings estimates were increased slightly, and 2015 estimates were introduced after meeting with management, UBS said. The new price target is $59 and is based on the new 2015 estimates, UBS said.

Qualcomm ( QCOM) was cut from the Conviction Buy List at Goldman Sachs. $80 price target. Chipset market share will likely peak in 2013, Goldman said.

Sally Beauty ( SBH) price target and estimates were raised at Sterne Agee. Estimates through 2014 were increased. The new $700 million share repurchase program presents material EPS accretion potential, Sterne Agee said. Price target is now $34.

Western Refining ( WNR) estimates were updated and its price target was raised at UBS. Earnings were moved from 2013 into 2014 after the company announced it is pursuing the formation of an MLP, UBS said. Price target was increased to $39.

Xilinx ( XLNX) price target and estimates were raised at UBS. Estimates through 2014 were increased. The company's ability to sustain 28nm market share leadership gives credence to new product execution, UBS said. Price target was increased to $37.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Will Inflation Set Stocks' Hearts Aflutter or Be a Poison Arrow? -- Market Recon

Will Inflation Set Stocks' Hearts Aflutter or Be a Poison Arrow? -- Market Recon

7 Investment Themes You Can't Afford to Miss for 2018

7 Investment Themes You Can't Afford to Miss for 2018

DOJ Seeks to Block AT&T's Acquisition of Time Warner: LIVE MARKETS BLOG

DOJ Seeks to Block AT&T's Acquisition of Time Warner: LIVE MARKETS BLOG

Wall Street Finishes in the Green After Two Weeks of Losses

Wall Street Finishes in the Green After Two Weeks of Losses

Consumer and Industrial Stocks Push Dow Higher After Two Weeks of Losses

Consumer and Industrial Stocks Push Dow Higher After Two Weeks of Losses